like book na is a political analyst, and john monet, professor in european studies at stanford university in belin. he says the chances resignation shows that a system of checks and balances is working in austria. well, the good thing is that this is not an authoritarian regime. apparently, it's a western type democratic system in which as we can see now the system of checks and balances worked pretty well. otherwise this regime quotes built to make it of one person show and not people's party that fault. he used to be before he came the chancellor. this is still the good news that everything works according to the constitution. and there is a system off. the separation of power still kind of works that the traditional system does its job. and most importantly, the free media can do what we expect meeting pre media to do in a situation like this. a government in the czech republic has lost its majority after this weekend's parliamentary election. and an opposition alliance says and now has the numbers to form the next administration. the prime minister party remains the single largest gro

once again, believe the pharmaceutical johns has monetize depends ethnic patients. when never designs full pandemic for public health emergencies, they should not in any situation get in the way of saving lives. and that is exactly what is happening now. but i think we also really have to remember the billions of dollars and your rise. i am pounds that have been put into the development of these vaccines. it wasn't the investment of pharmaceutical corporations, all that shareholders that made these vaccines possible. look at astrazeneca look at mcdonough, almost a 100 percent puppet be financed. this is tax pans, money that paid for the rapid development at these vaccines based on decade of research that was also public. the finance didn't about peyton's providing incentives. this is about peyton's protecting that monopolies and the grotesque profits, the pharmaceutical corporations. they have already made billions out of this pandemic. it's time to share the recipes, the rights to produce them, so that we can get this virus under control. facebook whistleblower fro

ah, my name is james and john carroll we bought a matter ah, monet. philadelphia was either past me soci soft amish. 2 a mom horrible. am this red bit of them a ha mish chad saw awful barbaric and they chatted balboa ah, ah, you want someone to next up with avenues? you're not gonna lose them at the corner. let me john hope, but shortly the so by this jury on bush. not about would that polish before what it is you can but joy of what for. call. the shorter my suits middle club pools. use a charlotte coburn, friend busy with all your tardies meet. i wanna go yeah. okay. you did tell her body. denise, as a broker to hop on julia charlotte. acosta. i've told has all, my, you well beat on your b. we'll start the in shot for a double shot. lady suck the had fallen a rose doughty mall that i'm bar and that sort of a catch on the if the holidays had sabina done had that i'm while them in jeannie added doctor who done no visa, shaw it a little that in kind of how he could enroll story and was up to them. ringback in there was no government really commissioning them to make films anymore, but the

anyways, we'll talk about this and joining us is john said this was a long-term bet on a active user base but robinhood isn't monetizing them quick enough and relying on the old tricks that got it here. do they get there? is this a good long-term bet >> yeah, i believe the robinhood model is, you know, still a good long-term bet. you had previously on cnbc the ceo who also talked about the model that they, you know, similar models but the disruptive models. they really brought in a new audience into investing. so, yeah, we're going to have quarter to quarter, you know, periods of revenues which weren't frankly as high as expected last night when they reported. but, you know, again, disruptive and i think they are changing the industry in the long term. >> right at the same time, we have been seeing robinhood deal more in crypto and there's always this sort of really tricky balance that robinhood and coinbase face which is being fast and quick versus being safe and complying or at least appeasing regulators you see that this morning with another meme coin trading on coinbase, but not on robinhood they seem to be taking

john crowley. congratulations on the deal. let me ask you how you plan to monetizeu see this growth happening as a result of spinning off. >> thank you, maria. good morning. good to be with you. amicus therapeutics we started to focus in the world of rare diseases and genetic medicines. we built the company now over 17 years to 500 people, more than a two and-a-half billion dollar market cap with a marketed product in fabray disease. we are looking for a second approved product which we're excited about. we've been building in the next generation after genetic medicine. we decided to separate the companies into two. amicus a very successful company with 500 employees around the world delivering medicines, developing late stage products in the field of rare unmet genetic diseases, but we're also very excited now about the spin-out company that i'll lead, again in the field of rare genetic medicines where we're going to be taking next generation genetic medicine gene therapy technology and i hope finally moving from treatment to more advanced treatments to ultimately